Page 1 of Clinical Trials for Biological non-adjuvanted A H1N1 influenza vaccine, 26 Total Matches

Show/Hide Clinical Trials Which are Not Seeking New Volunteers

1
Completed
Rapid Evaluation of Pandemic H1N1 Influenza Vaccines in Young Children
Last Updated: February 9, 2010
Condition(s): H1N1/2009 Influenza
2
Completed
A Study of Different Formulations of an Adjuvanted A/H1N1 Pandemic Vaccine in Healthy Adults and the Elderly
Last Updated: August 26, 2011
Condition(s): Influenza; Swine-origin A/H1N1 Influenza
3
Completed
A Study of the Immunogenicity of Swine-origin A/H1N1 Influenza Vaccine in Healthy Adults
Last Updated: April 15, 2011
Condition(s): Influenza; Swine-origin A/H1N1 Influenza
4
Completed
Immunogenicity, Safety and Tolerability of Two Doses of Adjuvanted and Non-adjuvanted Swine Origin A/H1N1 Monovalent Influenza Vaccine in Healthy Subjects 18 or More Years of Age
Last Updated: October 10, 2011
Condition(s): Pandemic Influenza
5
Completed
Immunogenicity, Safety and Tolerability of Two Doses of Adjuvanted and Non-adjuvanted Swine Origin A/H1N1 Monovalent Influenza Vaccine in Healthy Subjects 18 or More Years of Age
Last Updated: October 10, 2011
Condition(s): Pandemic Influenza
6
Completed
Immunogenicity, Safety and Tolerability of Two Doses of Adjuvanted and Non-adjuvanted Swine Origin A/H1N1 Monovalent Influenza Vaccine in Healthy Subjects From 6 Months to 17 Years of Age
Last Updated: October 7, 2011
Condition(s): Pandemic Influenza
7
Completed
Immunogenicity, Safety and Tolerability of Two Doses of Adjuvanted and Non-adjuvanted Swine Origin A/H1N1 Monovalent Influenza Vaccine (Egg-Derived) in Healthy Subjects From 6 Months to 17 Years of Age
Last Updated: October 10, 2011
Condition(s): Pandemic Influenza
8
Active, not recruiting
Clinical Trial to Compare the Immunogenicity, Safety, and Tolerability of an Adjuvanted A(H1N1) Influenza Vaccine Versus Non-Adjuvanted A(H1N1) Influenza Vaccines in Patients With Invasive Solid Tumors
Last Updated: February 6, 2012
Condition(s): H1N1 Influenza Virus; Invasive Solid Tumors
9
Active, not recruiting
Clinical Trial to Compare the Immunogenicity, Safety, and Tolerability of an Adjuvanted A(H1N1) Influenza Vaccine Versus Non-Adjuvanted A(H1N1) Influenza Vaccines in Patients With HIV-1 Infection
Last Updated: February 6, 2012
Condition(s): H1N1 Influenza Virus; Human Immunodeficiency Virus Type 1 (HIV-1) Infection
10
Active, not recruiting
Clinical Trial to Compare the Immunogenicity, Safety, and Tolerability of an Adjuvanted A(H1N1) Influenza Vaccine Versus Non-Adjuvanted A(H1N1) Influenza Vaccines in Patients With Chronic Pulmonary Disease, Chronic Heart Disease, or Diabetes Mellitus
Last Updated: February 6, 2012
Condition(s): H1N1 Influenza Virus; Chronic Pulmonary Disease; Chronic Heart Disease; Diabetes Mellitus
11
Completed
Immunogenicity and Safety of an Inactivated Split-virion 2009 Pandemic Influenza A H1N1 Vaccine in Infants
Last Updated: December 16, 2011
Condition(s): Influenza
12
Completed
Study of Swine-Origin A/H1N1 Influenza Non-Adjuvanted Vaccine in Healthy Adults in India
Last Updated: April 15, 2011
Condition(s): Influenza; Pandemic Influenza; Influenza A Virus, H1N1 Subtype
13
Completed
Clinical Trial to Evaluate the Immunogenicity and Safety of an Adjuvanted A(H1N1)v Influenza Vaccine and a Non-adjuvanted A(H1N1)v Influenza Vaccine in HIV-infected Patients (ANRS 151 Hifluvac)
Last Updated: December 21, 2011
Condition(s): HIV Infections
14
Active, not recruiting
Safety and Efficacy of Anti-Pandemic H1N1 Vaccination in Rheumatic Diseases
Last Updated: June 25, 2010
Condition(s): Rheumatoid Arthritis; Spondyloarthritis; Systemic Lupus Erythematosus (SLE); Dermatomyositis (DM); DMixed Connective Tissue Disease; Systemic Vasculitis; Systemic Sclerosis (SSc); Sjögren's Syndrome; Antiphospholipid Syndrome; Juvenile Idiopathic Arthritis; Juvenile SLE; Juvenile DM
15
Active, not recruiting
The Long-term Immunogenicity of an Inactivated Split-virion 2009 Pandemic Influenza A H1N1 Vaccine
Last Updated: April 14, 2011
Condition(s): Influenza
16
Completed
Safety and Immunogenicity of A/H1N1-SOIV (Swine Flu) Vaccine With and Without Adjuvant in Children, Adolescents and Adults (3 to 64 Years)
Last Updated: April 22, 2011
Condition(s): Novel 2009 Influenza H1N1
17
Completed
Immunogenicity and Safety of an Inactivated Non-adjuvanted A(H1N1)v Influenza Vaccine in Pregnant Women
Last Updated: December 29, 2011
Condition(s): Influenza
18
Completed
Safety and Immunogenicity of A/H1N1-SOIV (Swine Flu) Vaccine With and Without Adjuvant in Children (3 to < 9 Years)
Last Updated: December 7, 2011
Condition(s): Influenza
19
Active, not recruiting
Basic and Clinical Research on Applying Blood Fix to Treat Critical H1N1 Patients
Last Updated: January 25, 2010
Condition(s): Virus Diseases; Respiratory Tract Diseases; Respiratory Tract Infections; Influenza; Orthomyxoviridae Infections
20
Completed
Safety and Immunogenicity of A/H1N1-SOIV (Swine Flu) Vaccine With and Without Adjuvant in Non-Elderly and Elderly Adults
Last Updated: December 7, 2011
Condition(s): Influenza

Clinical Trials content is provided directly by the U.S. National Institutes of Health via ClinicalTrials.gov and is not reviewed separately by ClinicalTrialsFeeds.org. Every page of specific clinical trials information contains a unique identifier which can be used to find further details directly from the National Institutes of Health.

The URL of this page is: http://clinicaltrialsfeeds.org/clinical-trials/results/?term=Biological+non-adjuvanted+A+H1N1+influenza+vaccine

Page 1 of Clinical Trials for Biological non-adjuvanted A H1N1 influenza vaccine, 26 Total Matches

Get the Latest Results via Email or RSS

Subscribe via Web Newsreaders

Browse

Clinical Trials Background

About